Cisen Pharmaceutical Co Ltd. Stock Analysis 603367.SS

Cisen Pharmaceutical Ltd. engages in the manufacture and distribution of comprehensive chemical and pharmaceutical products. The company is headquartered in Jining, Shandong and currently employs 3,114 full-time employees. The company went IPO on 2017-09-29. The firm is principally engaged in the research and development, production and sales of general infusions, nutritional infusions, anti-infective drugs, cardiovascular and cerebrovascular drugs, liver disease drugs, digestive system drugs, anti-tumor drugs and auxiliary drugs. The firm's primary products include large infusion products, small volume injections, oral solid preparations, freeze-dried powder injections, irrigants, drops, ointments and raw materials. The firm principally conducts its businesses in domestic and overseas markets.